Collegium Pharmaceutical Inc

NASDAQ:COLL  
15.94
+0.40 (+2.57%)
Earnings Announcements

Collegium Reports First Quarter 2022 Financial Results

Published: 05/10/2022 20:12 GMT
Collegium Pharmaceutical Inc (COLL) - Collegium Reports First Quarter 2022 Financial Results.
Q1 Revenue $83.8 Million.
Total Net Product Revenues Were $83.8 Million for Quarter Ended March 31, 2022, Compared to $87.7 Million.
Qtrly Net Loss Was $0.39 Loss per Share.
Q1 Earnings per Share View $0.90, Revenue View $78.9 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $122.05 Million
Adjusted EPS is expected to be $1.51

Next Quarter Revenue Guidance is expected to be $124.5 Million
Next Quarter EPS Guidance is expected to be $1.53

More details on our Analysts Page.